ANI Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIP and other ETFs, options, and stocks.

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. 

CEO
Nikhil Lalwani
CEONikhil Lalwani
Employees
970
Employees970
Headquarters
Baudette, Minnesota
HeadquartersBaudette, Minnesota
Founded
1996
Founded1996
Employees
970
Employees970

ANIP Key Statistics

Market cap
1.66B
Market cap1.66B
Price-Earnings ratio
22.32
Price-Earnings ratio22.32
Dividend yield
Dividend yield
Average volume
280.60K
Average volume280.60K
High today
$76.27
High today$76.27
Low today
$74.21
Low today$74.21
Open price
$75.10
Open price$75.10
Volume
271.83K
Volume271.83K
52 Week high
$99.50
52 Week high$99.50
52 Week low
$56.71
52 Week low$56.71

Stock Snapshot

As of today, ANI Pharmaceuticals(ANIP) shares are valued at $74.21. The company's market cap stands at 1.66B, with a P/E ratio of 22.32.

As of 2026-04-03, ANI Pharmaceuticals(ANIP) stock has fluctuated between $74.21 and $76.27. The current price stands at $74.21, placing the stock 0.0% above today's low and -2.7% off the high.

The ANI Pharmaceuticals(ANIP)'s current trading volume is 271.83K, compared to an average daily volume of 280.6K.

In the last year, ANI Pharmaceuticals(ANIP) shares hit a 52-week high of $99.50 and a 52-week low of $56.71.

In the last year, ANI Pharmaceuticals(ANIP) shares hit a 52-week high of $99.50 and a 52-week low of $56.71.

ANIP News

Simply Wall St 2d
A Look At ANI Pharmaceuticals Valuation After Mixed Short Term Share Price Moves

Advertisement Why ANI Pharmaceuticals (ANIP) is On Investors’ Radar Today ANI Pharmaceuticals (ANIP) has drawn fresh attention after recent share price moves,...

A Look At ANI Pharmaceuticals Valuation After Mixed Short Term Share Price Moves
Simply Wall St 7d
Is Record 2025 Sales And 2026 Guidance Past US$1 Billion Altering The Investment Case For ANI Pharmaceuticals?

ANI Pharmaceuticals recently reported record 2025 revenue of US$883.4 million, driven largely by strong growth in its Rare Disease segment and Cortrophin Gel, w...

Is Record 2025 Sales And 2026 Guidance Past US$1 Billion Altering The Investment Case For ANI Pharmaceuticals?
The Motley Fool 7d
ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025

Thomas Rowland, an executive at ANI Pharmaceuticals (ANIP 1.78%), reported the sale of 4,772 shares of common stock in an open-market transaction on March 11, 2...

ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own ANIP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.